(Q45748929)

15 December 2017

title

Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure (English)

1 reference

15 December 2017

1 reference

1

1 reference

15 December 2017

author name string

F von Breunig

2

1 reference

15 December 2017

T Santantonio

3

1 reference

15 December 2017

M C Jung

4

1 reference

15 December 2017

G B Gaeta

5

1 reference

15 December 2017

L Fischer

6

1 reference

15 December 2017

M Sterneck

7

1 reference

15 December 2017

H Will

8

1 reference

15 December 2017

publication date

1 May 1999

1 reference

15 December 2017

published in

Journal of Hepatology

1 reference

15 December 2017

volume

30

1 reference

15 December 2017

page(s)

749-754

1 reference

15 December 2017

issue

5

1 reference

15 December 2017

Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

Identification of four conserved motifs among the RNA-dependent polymerase encoding elements

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

Effects of lamivudine on replication of hepatitis B virus in HIV-infected men.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

Pretransplant famciclovir as prophylaxis for hepatitis B virus recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

Conversion of recurrent delta-positive hepatitis B infection to seronegativity with famciclovir after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

Famciclovir therapy for recurrent hepatitis B virus infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-beta-L-2',3'-dideoxy-3'-thiacytidine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

Inhibitory Effect of Penciclovir-Triphosphate on Duck Hepatitis B Virus Reverse Transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

Lamivudine resistance inimmunocompetent chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

Role of additional mutations outside the YMDD motif of hepatitis B virus polymerase in L(-)SddC (3TC) resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980124-X

7 January 2021

10.1016/S0168-8278(99)80124-X

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

10365797

1 reference

15 December 2017